Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Bachman

Eppendorf announced that Thomas Bachman was appointed CEO on August 1, 2015. Bachman is taking over for Detmar Ammerman, who took on the role of CEO in addition to his responsibilities as CFO upon the departure of the previous CEO. Bachman has been a member of Eppendorf's supervisory board since 2013. Before joining Eppendorf, he held a position as president of Burker BioSpin. He has been active in the life science sector since 2005, when he managed the Tecan group, headquartered in Switzerland.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.